Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Infiltration vs. Surgical Infiltration in Hysterectomy
NCT02519023Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liposomal bupivacaine in acute pain (2 arms), sponsored by University of Minnesota. Primary endpoint: Total Opioid Use for Pain Control at 72 hours. Started Jul 2016; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02519023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519023.